This website is intended for healthcare professionals

Systemic anti cancer therapy

Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym

Safe compounding of chemotherapy has historically received more attention than drug administration (Santillo et al, 2018), and guidelines for nursing safety vary considerably across Europe. Depending...

A prospective audit evaluating use of urokinase in oncology patients with occluded central venous access devices

The aim of this audit was to evaluate safety and outcome following use of urokinase (Syner-Kinase®) using a push lock or dwell lock technique; followed by high-dose infusion if the lock was...

Non-medical prescribing of systemic anticancer therapy in a multidisciplinary team oncology clinic

As Lead Nurse of the Royal Free London NHS Foundation Trust Neuroendocrine Tumour Unit (a European Neuroendocrine Tumour Society (ENETS) centre of excellence), the author wanted to help improve the...

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP